Sectra to Provide Large Centralized Regional Solution for Digital Pathology in the UK

SectraInternational medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a five-year contract with North Tees and Hartlepool NHS Foundation Trust for the delivery of a regional digital pathology solution to the Northern Cancer Alliance. The solution will span the ten separate trusts of the consortium and aims to improve cancer care workflows through enabling pathologists to instantly access and share images and information between departments and locations.

"Digital pathology will be an enabler for collaborative working across large geographic areas, streamlining pathology diagnostic decision making, particularly for cancer diagnosis and multidisciplinary team meeting discussions. This represents the biggest and most exciting change to the way Cellular Pathologist work in a generation." says Dr Paul Barrett, histopathologist at County Durham and Darlington NHS Foundation Trust and co-clinical lead of the project.

Dr Sonali Natu, histopathologist at North Tees and Hartlepool NHS Foundation Trust and the other co-clinical lead of the project, adds "As an integrated health and care system, we need to move away from isolation and head towards integration. This platform will deliver a large part of that ambition for the patients we serve. The digital access to pathology images and digital tools for reviewing them will in the end translate into easier collaboration, more resilient services and improved patient care."

The solution will support 115 pathologists across the trusts, conducting an average of 300,000 examinations a year. Through Sectra's central solution, they will be able to access all pathology images produced by the consortium and get one consolidated view of a patient record from a single interface.

Digital pathology will give the pathologists functionality beyond the microscope. Without the need for physical glass slides, digital access to current and historical images is enabled from anywhere and at any time. The digital solution provides pathologists with assistance at critical decision points, such as grading or doing more precise measurements. It also enables image analysis, which in turn reduces variation and improves the precision of tasks such as cell counting. The digital access further facilitates second opinions, external reading resources, specialist consultations and regional MDT case review meetings.

The trusts within the regional solution will be using PACS based reporting and integrate with multiple local Laboratory Information Management Systems (LIMS). This could for example facilitate workload balancing across the consortium and equal access to specialists for all patients in the region. The contract extension was signed during the fourth quarter of the fiscal year.

About Sectra's Digital Pathology Solution

Sectra's digital pathology solution includes digital tools which enable the pathologists to make their diagnoses and carry out reporting with higher precision and less time spent per case. It is a complete, vendor-neutral solution for primary diagnostics that includes storage solutions and an advanced review workstation. Watch this video to learn more about how digital pathology can enable increased efficiency and higher precision for the pathologists.

Sectra's pathology solution is part of Sectra's enterprise imaging offering. It provides a unified strategy for all imaging needs, and improves patient outcomes while lowering operational costs. The scalable and modular solution supports the most image-intense departments - radiology, breast imaging, pathology, cardiology and orthopaedics. Being built on the same technical platform, customers can easily extend a departmental solution to create a comprehensive VNA.

About Sectra

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2018/2019 fiscal year totaled SEK 1,413 million. The Sectra share is quoted on the Nasdaq Stockholm exchange.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...